Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4412426 | 4193470 | I | 4412426-0 | 20040317 | 20040401 | 20040630 | PER | 04P-163-0255854-00 | PPD PHARMACOVIGILANCE | 55 | YR | F | N | 200 | LBS | 20040401 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4412426 | 1005064568 | PS | HUMIRA | 1 | SUBCUTANEOUS | 40 MG, 1 IN 2 WK, SUBCUTANEOUS | D | D | |||
| 4412426 | 1005127794 | C | HYDROXYCHLOROQUINE SULFATE | 1 | |||||||
| 4412426 | 1005127795 | C | ROFECOXIB | 1 | |||||||
| 4412426 | 1005127796 | C | LEVOTHYROXINE SODIUM | 1 | |||||||
| 4412426 | 1005127797 | C | CONJUGATED ESTROGEN | 1 | |||||||
| 4412426 | 1005127798 | C | PROGESTERONE | 1 | |||||||
| 4412426 | 1005127799 | C | METHOTREXATE | 2 | |||||||
| 4412426 | 1005127800 | C | SULFATHOXIZOLE | 2 | |||||||
| 4412426 | 1005127801 | C | LEVOFLOXACIN | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4412426 | 1005064568 | RHEUMATOID ARTHRITIS |
Outcome of event
| no results found |
Reactions reported
| Event ID | PT |
|---|---|
| 4412426 | INJECTION SITE BURNING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4412426 | CSM |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4412426 | 1005064568 | 20040317 |